# Top 50 Biotechnology Angel Investors in United States in June 2026

## Milad Alucozai
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 17
- Stages: Seed, Series A, Pre-Seed
- Focus: Biotechnology, Health Care, Medical

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

## Jeff Dean
- Type: Angel
- Location: Palo Alto, California, United States
- Relevant deals: 13
- Stages: Seed, Series A, Pre-Seed
- Focus: Artificial Intelligence, Information Technology, Software

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

## Jaffray Woodriff
- Type: Angel
- Location: Charlottesville, Virginia, United States
- Relevant deals: 10
- Stages: Seed, Series A, Angel
- Focus: Software, Biotechnology, Health Care

Angel Investor located in Charlottesville, VA

## Kingsley Advani
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 9
- Stages: Seed, Pre-Seed, Series A
- Focus: FinTech, Biotechnology, Financial Services

Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.

## Farzad Nazem
- Type: Angel
- Location: Palo Alto, California, United States
- Relevant deals: 9
- Stages: Seed, Series A, Series B
- Focus: Health Care, Software, Analytics

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007.  He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School.  His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007.  He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees.  Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division.  His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products.  Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division.  At age 19, he earned a B.S. degree in Computer Science with highest honors.

## Jude Gomila
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 9
- Stages: Seed, Pre-Seed, Angel
- Focus: Software, Biotechnology, Information Technology

Jude Gomila is currently CEO and Founder of the startup Golden.

## bumpkins profile
- Type: Angel
- Relevant deals: 8
- Stages: Seed, Series A, Pre-Seed
- Focus: Health Care, Biotechnology, Robotics

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

## Sahin Boydas
- Type: Angel
- Location: San Francisco Bay Area, California, United States
- Relevant deals: 8
- Stages: Seed, Series A, Series B
- Focus: Software, Financial Services, Information Technology

Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.

## Sam Altman
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 8
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, Internet

Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.

## Paul Buchheit
- Type: Angel
- Location: Mountain View, California, United States
- Relevant deals: 8
- Stages: Seed, Series A, Angel
- Focus: Software, E-Commerce, Health Care

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

## Jeff Hammerbacher
- Type: Angel
- Relevant deals: 7
- Stages: Seed, Series A, Angel
- Focus: Software, Artificial Intelligence, Biotechnology

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

## Alice Zhang
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 7
- Stages: Seed, Series A, Pre-Seed
- Focus: Biotechnology, Health Care, Medical

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

## Zach Weinberg
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 6
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Health Care, SaaS

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

## Wei Guo
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 6
- Stages: Seed, Series A, Angel
- Focus: Software, Artificial Intelligence, Health Care

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

## Mark Cuban
- Type: Angel
- Location: Dallas, Texas, United States
- Relevant deals: 5
- Stages: Seed, Series A
- Focus: Software, Artificial Intelligence, Blockchain

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

## Chris Gibson
- Type: Angel
- Location: Salt Lake City, Utah, United States
- Relevant deals: 5
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Life Science

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

## John Ballantyne
- Type: Angel
- Location: Fargo, North Dakota, United States
- Relevant deals: 5
- Stages: Seed, Series A, Angel
- Focus: Biotechnology, Health Care, Life Science

John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.

## Balaji Srinivasan
- Type: Angel
- Location: San Francisco Bay Area, California, United States
- Relevant deals: 5
- Stages: Seed, Pre-Seed, Series A
- Focus: Blockchain, Cryptocurrency, Software

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

## Daniel Curran
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 5
- Stages: Seed, Series A, Series B
- Focus: E-Commerce, Software, Internet

Daniel Curran is the Founder and CEO at CustEx.com.

## Jim Mellon
- Type: Angel
- Relevant deals: 5
- Stages: Series A, Seed
- Focus: Biotechnology, Food and Beverage, Health Care

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

## Anne Wojcicki
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 5
- Stages: Seed, Series A, Series B
- Focus: Health Care, Medical, Biotechnology

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

## Fred Ehrsam
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 5
- Stages: Seed, Series A, Series C
- Focus: Blockchain, Cryptocurrency, Software

Fred Ehrsam is the Co-Founder of Paradigm.

## Erik Peterson
- Type: Angel
- Location: Chicago, Illinois, United States
- Relevant deals: 5
- Stages: Seed, Equity Crowdfunding, Series A
- Focus: Software, Biotechnology, SaaS

Erik Peterson is the Founder at DormTrader.

## Brian Armstrong
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 5
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Payments, Financial Services

Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.

## Evan Cheng
- Type: Angel
- Location: Burlingame, California, United States
- Relevant deals: 5
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Artificial Intelligence, Biotechnology

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

## Elad Gil
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 5
- Stages: Seed, Series A, Series B
- Focus: Software, Information Technology, Artificial Intelligence

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

## Kevin Moore
- Type: Angel
- Location: Dallas, Texas, United States
- Relevant deals: 5
- Stages: Seed, Pre-Seed, Angel
- Focus: Software, Health Care, E-Commerce

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates. 

## Daren Cotter
- Type: Angel
- Location: Minneapolis, Minnesota, United States
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, Health Care, E-Commerce

Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.

## Esther Dyson
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Health Care, Software, Medical

Esther Dyson - Founder @ Way to Wellville

## John D'Orazio
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 4
- Stages: Seed, Equity Crowdfunding
- Focus: Medical, Health Care, Biotechnology

John D'Orazio is the Founder and Managing Partner of Proton Enterprises. He previously worked at SlideMoor as an Executive Partner. John D'Orazio attended Xavier University.

## Nat Turner
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Health Care, Software, Medical

Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.

## Bradley Horowitz
- Type: Angel
- Location: Palo Alto, California, United States
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Software, Information Technology, Artificial Intelligence

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation.  He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

## Brenton Saunders
- Type: Angel
- Location: Parsippany, New Jersey, United States
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Health Care, Medical, Biotechnology

Brenton Saunders is the current Chief Executive Officer of Bausch & Lomb. He previously worked at The Allergan Foundation as a Chairman. Brenton Saunders attended Temple University’s Fox School of Business.

## Bill Gates
- Type: Angel
- Location: Seattle, Washington, United States
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Energy, Biotechnology, Manufacturing

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

## Timothy A. Springer
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 4
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Medical, Health Care

Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.

## Alec Nielsen
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 4
- Stages: Seed, Pre-Seed
- Focus: Biotechnology, Biopharma, Medical

Alec Nielsen is the Founder & CEO at Asimov.

## Cory Levy
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Pre-Seed, Seed, Series A
- Focus: Artificial Intelligence, Software, Advertising

Cory Levy is the Founder of Z Fellows. He previously worked at DoSomething.org as a Board Member. Cory attended University of Illinois Urbana-Champaign, where he took Computer Science.

## Max Levchin
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Series A, Seed, Series B
- Focus: FinTech, Financial Services, Mobile

Max Levchin is the Founder and CEO of Affirm. He previously worked at the Consumer Financial Protection Bureau as an Advisory Board Member. Max Levchin attended the University of Illinois Urbana-Champaign.

## Darian Shirazi
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Software, Information Technology, Artificial Intelligence

Darian Shirazi is the Managing Partner of Gradient.

## Avichal Garg
- Type: Angel
- Location: Stanford, California, United States
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, Blockchain, Internet

Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.

## Jack Abraham
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Health Care, Software, Biotechnology

Jack Abraham is based out of Florida and is the Chairman and Co-Founder of Indomo. Jack previously worked at TalkIQ as a Co-Founder and Investor. Jack Abraham attended The Wharton School.

## Peter Thiel
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Series A, Seed, Series B
- Focus: Software, FinTech, Financial Services

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

## Todd Corenson
- Type: Angel
- Location: Los Gatos, California, United States
- Relevant deals: 4
- Stages: Seed, Pre-Seed, Convertible Note
- Focus: Biotechnology, FinTech, SaaS

Todd Corenson - Founder @ Enlon

## David R. Walt
- Type: Angel
- Location: Boston, Massachusetts, United States
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Genetics, Life Science

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

## Ling Wong
- Type: Angel
- Location: Seattle, Washington, United States
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.

## Eric Kwan
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Seed, Pre-Seed
- Focus: FinTech, Software, E-Commerce

Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures

## David Beyer
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Seed, Series A, Angel
- Focus: Software, Artificial Intelligence, Machine Learning

David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.

## Brad Flora
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Pre-Seed, Seed, Series A
- Focus: Software, Artificial Intelligence, SaaS

Brad Flora is a Visiting Partner at Y Combinator. He is a former Co-Founder and CEO of Perfect Audience.

Mr. Flora received a BA from Princeton University in English and an MS in Journalism from Northwestern.

## Jason Calacanis
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 3
- Stages: Pre-Seed, Seed, Series A
- Focus: Software, Internet, Artificial Intelligence

Jason Calacanis is the Founder and CEO of Inside.com and Launch. He previously worked at Weblogs as a Co-Founder and CEO. Jason Calacanis attended Fordham University.

## Erik Moore
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Mobile, Software, E-Commerce

Erik Moore is the Founder and Managing Director of Base Ventures, an early-stage tech venture fund. He was one of the first investors in Zappos (sold for 1.2B to Amazon) and an early investor in Plangrid, sold to Autodesk for $875mm. Prior to Base Ventures, Erik spent 15 years in investment banking at Merrill Lynch. He recently joined the boardof the Common Ground Foundation, founded by Grammy, Oscar and Emmy award winning artist, Common, and he currently serves as a board member for P.A.C.E, a private philanthropic group. He was recognized as #10 on a list of the top 25 most influential blacks in tech by Business Insider (John Thompson, Chairman of Microsoft was ranked #1). He mentors and advises several known professional athletes. Erik earned his B.A. from Dartmouth College, an MA in French from the University of Pennsylvania, and his MBA from The Wharton School of Business.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co